New DIR rule expected, key congressional committees to grill PBMs next week
As pharmacy benefit manager executives prepare to be hauled before Congress next week to defend their business practices, community pharmacists are eagerly awaiting release of a drug pricing rule that, if finalized as proposed, would move pharmacy price concessions to point-of-sale, eliminating the